ARCHIVES

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Plans $40M In Grants For Cancer Outcomes Studies.

June 30, 2000

In Brief: House, Senate Enact FY ’92 Budget Bills For NCI That Differ By $200 Million; Senate’s Is Higher

September 27, 1991

Funding opportunities listed.

July 23, 2004

Michael Link Elected ASCO President.

January 15, 2010

Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs”

April 27, 2012

Vanderbilt Wins NCI Core Grant Renewal with 12.7 Percent Funding increase

December 3, 2010